ZeroStack Corp. (ZSTK)
ZSTK Stock Price Chart
Explore ZeroStack Corp. interactive price chart. Choose custom timeframes to analyze ZSTK price movements and trends.
ZSTK Company Profile
Discover essential business fundamentals and corporate details for ZeroStack Corp. (ZSTK) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Distribution
IPO Date
11 May 2021
Employees
21.00
Website
https://zerostack.aiCEO
Daniel Reis-Faria
Description
ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.
ZSTK Financial Timeline
Browse a chronological timeline of ZeroStack Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 17 Aug 2026
EPS estimate is -$0.11, while revenue estimate is $7.30m.
Earnings released on 1 May 2026
EPS came in at -$3.68 falling short of the estimated -$1.18 by -211.86%, while revenue for the quarter reached $7.27m , missing expectations by -44.47%.
Earnings released on 23 Mar 2026
EPS came in at -$35.32 falling short of the estimated -$0.17 by -20.73k%, while revenue for the quarter reached -$654.00k , missing expectations by -104.28%.
Earnings released on 5 Nov 2025
EPS came in at -$4.93 falling short of the estimated -$2.13 by -131.46%, while revenue for the quarter reached $9.75m , missing expectations by -22.02%.
Stock split effective on 4 Aug 2025
Shares were split 1 : 39 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Aug 2025
EPS came in at -$4.30 falling short of the estimated -$2.34 by -83.76%, while revenue for the quarter reached $14.80m , beating expectations by +25.39%.
Earnings released on 13 May 2025
EPS came in at -$1.56 falling short of the estimated -$0.39 by -300.00%, while revenue for the quarter reached $11.79m , missing expectations by -20.36%.
Earnings released on 24 Mar 2025
EPS came in at -$16.41 falling short of the estimated -$6.63 by -147.51%, while revenue for the quarter reached $13.33m , missing expectations by -1.29%.
Earnings released on 13 Nov 2024
EPS came in at -$0.83 surpassing the estimated -$3.43 by +75.77%, while revenue for the quarter reached $12.47m , missing expectations by -25.66%.
Earnings released on 12 Aug 2024
EPS came in at -$8.59 falling short of the estimated -$1.72 by -398.32%, while revenue for the quarter reached $15.68m , missing expectations by -24.38%.
Earnings released on 14 May 2024
EPS came in at -$10.94 falling short of the estimated -$8.49 by -28.91%, while revenue for the quarter reached $18.03m , missing expectations by -5.30%.
Earnings released on 29 Mar 2024
EPS came in at -$0.17 falling short of the estimated -$0.07 by -142.86%, while revenue for the quarter reached $17.19m , beating expectations by +4.06%.
Earnings released on 8 Nov 2023
EPS came in at -$1.95 surpassing the estimated -$7.81 by +75.03%, while revenue for the quarter reached $17.32m , missing expectations by -17.93%.
Earnings released on 10 Aug 2023
EPS came in at -$6.58 falling short of the estimated -$0.40 by -1.55k%, while revenue for the quarter reached $21.46m , beating expectations by +3.17%.
Stock split effective on 9 Jun 2023
Shares were split 1 : 20 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 15 May 2023
EPS came in at -$0.59 surpassing the estimated -$0.70 by +15.71%, while revenue for the quarter reached $20.11m , missing expectations by -12.41%.
Earnings released on 31 Mar 2023
EPS came in at -$1.17 falling short of the estimated -$0.70 by -66.68%, while revenue for the quarter reached $11.50m , missing expectations by -11.35%.
Earnings released on 28 Nov 2022
EPS came in at -$1.92 falling short of the estimated -$0.07 by -2.64k%, while revenue for the quarter reached $10.77m , missing expectations by -5.18%.
Earnings released on 15 Aug 2022
EPS came in at -$7.40 falling short of the estimated -$0.02 by -36.90k%, while revenue for the quarter reached $14.90m , beating expectations by +44.43%.
Earnings released on 10 May 2022
EPS came in at -$2.16 falling short of the estimated -$0.02 by -10.70k%, while revenue for the quarter reached $4.95m .
Earnings released on 31 Dec 2021
EPS came in at -$4.79 falling short of the estimated -$0.05 by -9.48k%, while revenue for the quarter reached $4.77m , beating expectations by +76.63%.
Earnings released on 17 Sept 2021
EPS came in at -$0.55 falling short of the estimated -$0.00 by -18.13k%, while revenue for the quarter reached $1.16m , missing expectations by -17.21%.
ZSTK Stock Performance
Access detailed ZSTK performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
